Market Tracker

01/30 8:43am ET

SPDR® S&P Biotech ETF (XBI)

Thursday’s Trading Day
202.01 +2.82 / +1.42%
Data as of Jan 29
Day’s Change
Friday’s Pre-Market   Switch to standard view »
204.00 +1.99 / +0.99%
 
Volume: 150.00

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+7.72% 3 years+38.94%
3 months+19.42% 5 years+29.96%
1 year+36.33% Since inception+17.32%
Data through 01/30/2015

Quote Details

Previous close$199.19
Open day’s range-- – --
Net asset value (NAV)201.95 (01/29/2015)
Daily volume409,977
Average volume (3 months)542,714
Data as of 01/29/2015

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+29.96%+22.29%
Expense Gross exp ratio0.35%0.44%
Risk 5 year sharpe ratio1.151.44
Net assets$1.5B$1.5B
Average market cap$2.0B$34.2B
Average P/E--25.1
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RPTP Raptor Pharmaceutical Corp1.45%
OPK Opko Health Inc1.42%
BCRX Biocryst Pharmaceuticals Inc1.41%
HALO Halozyme Therapeutics Inc1.40%
ENTA Enanta Pharmaceuticals Inc1.37%
NPSP NPS Pharmaceuticals Inc1.33%
ONVO Organovo Holdings Inc1.33%
ICPT Intercept Pharmaceuticals Inc1.32%
CMRX Chimerix Inc1.32%
VNDA Vanda Pharmaceuticals Inc1.31%